Sublingual THC Dosing Recommendations
Start sublingual THC at the lowest possible dose (approximately 2.5 mg THC) and titrate slowly upward over 1-2 weeks, with a general maximum daily dose of 30 mg THC to minimize adverse effects, particularly in cannabis-naïve patients and older adults. 1, 2
Starting Dose and Titration Strategy
The 2024 ASCO guideline emphasizes a "start low, go slow" approach for all cannabis/cannabinoid products 1. While the guideline doesn't specify exact sublingual dosing (as most evidence focuses on oral synthetic cannabinoids like dronabinol and nabilone), the principles apply:
- Initial dose: Begin at 2.5 mg THC or less
- Titration period: Increase gradually over 1-2 weeks 2
- Maximum daily dose: Generally limit to 30 mg THC per day or less to avoid psychoactive effects and tolerance development 2
- Timing between doses: Allow sufficient time (several hours) between doses to assess effects before increasing 1
Key Pharmacokinetic Considerations for Sublingual Route
Sublingual administration falls between oral and inhaled routes in terms of onset and bioavailability:
- Oral THC: 4-12% bioavailability, onset 30 minutes to 2 hours, duration 5-8 hours 1
- Inhaled THC: 10-35% bioavailability, onset seconds to minutes, duration 2-3 hours 1
- Sublingual likely provides intermediate characteristics
Critical warning: Patients must wait ≥1 hour after dosing before considering additional doses to avoid "stacking" and subsequent overdose symptoms (euphoria, drowsiness, dizziness, vertigo, hallucinations) 1
Special Population Considerations
Older Adults and Cannabis-Naïve Patients
- Use extra caution with starting doses
- These populations are at higher risk for adverse effects including falls, confusion, and orthostatic hypotension 1
- Consider starting even lower than 2.5 mg if available
Patients on Specific Medications
Monitor for drug interactions via CYP450 enzyme inhibition 1:
- Very high risk: Warfarin
- High risk: Buprenorphine, tacrolimus
- Moderate concern: Chemotherapeutic agents metabolized by CYP3A4, CYP2C9, CYP2C19
Common Adverse Effects to Monitor
Short-term effects (dose-related):
- Dizziness, drowsiness, confusion, dry mouth, fatigue
- Tachycardia, orthostatic hypotension
- Severe confusion, paranoia (at higher doses) 1
Important safety note: Unlike opioids, THC overdose does not cause respiratory depression, but can be distressing and increase fall risk 1
Practical Dosing Algorithm
- Screen for contraindications: Active psychosis, unstable cardiovascular disease, pregnancy/breastfeeding
- Check medication list: Identify high-risk drug interactions (warfarin, buprenorphine, tacrolimus)
- Start at 2.5 mg THC sublingually once or twice daily
- Wait 3-7 days before increasing dose
- Increase by 2.5 mg increments if inadequate effect and no adverse events
- Target therapeutic effect while staying ≤30 mg total daily THC
- Monitor closely for neuropsychiatric effects, falls, cardiovascular symptoms
Food Interactions
While this applies more to oral administration, high-fat meals significantly increase cannabinoid absorption and may exacerbate side effects 1. Advise consistent timing relative to meals.
Long-Term Safety Threshold
Recent research suggests weekly consumption thresholds for cannabis use disorder risk:
- Adults: 8.26 standard THC units/week (approximately 41 mg THC/week) for any CUD risk 3
- This translates to roughly 6 mg THC daily as a safer long-term threshold
The evidence base for specific sublingual THC dosing remains limited, with most guideline recommendations extrapolated from oral synthetic cannabinoids (dronabinol, nabilone) and general cannabis pharmacology principles 1.